(Total Views: 506)
Posted On: 06/08/2021 10:37:27 AM
Post# of 154928
Re: Shelly2626 #93095
The LH trial should be completed the 1st or 2nd week of August given the 56 day assessment period for improvement over many different parameters.
There is a follow-up safety assessment period of 35 days after the 56 days are done. My guess is that the results will be processed and reported after 56 days, since that covers leronlimab's possible efficacy, and that the safety results will be added as an addendum later but that's something I'd be interested in getting clarity on at some point.
Anyway, results some time later in August would be my guess.
There is a follow-up safety assessment period of 35 days after the 56 days are done. My guess is that the results will be processed and reported after 56 days, since that covers leronlimab's possible efficacy, and that the safety results will be added as an addendum later but that's something I'd be interested in getting clarity on at some point.
Anyway, results some time later in August would be my guess.
(2)
(0)
